DANICOM
ActiveSummary
DANICOM has been active since 1998 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €612,759 and a net result of €93,207. Equity is growing by ~9.7% per year across the filed fiscal years. Its solvency ranks better than 95% of 16754 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability87▲+5
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €55,000 at 30 days acceptable
Liquidity ample (current ratio 34.71 against 7.51 in 2024; short-term debt: 2.6% and cash: 14% of total assets), and 2.6% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
97.4%
Return on assets
14.8%
Age of the figures
9 mo
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-08-2026, 20 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filingsDeviation from the deadline
2025
20 d late
2024
9 d early
2023
47 d early
2022
22 d late
2021
45 d early
2020
2 d early
2019
28 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 5 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 22 July (4 of the last 5 filed years within 36 days of that day).
Companies Code · seven monthsPosition in the running window
28-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€612,759▲ 17.9%
2024 · €519,552
Total assets
€629,243▲ 6.8%
2024 · €588,911
Net result
€93,207▲ 54.3%
2024 · €60,420
Working capital
€555,679▲ 23.1%
2024 · €451,330
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€80,330€181,557▲ 126%€171,276▼ 5.7%€91,352▼ 46.7%€104,965▲ 14.9%
Net result€60,656within the sector's middle half€125,089above the sector's middle half▲ 106%€116,535above the sector's middle half▼ 6.8%€60,420within the sector's middle half▼ 48.2%€93,207within the sector's middle half▲ 54.3%
Equity€416,070above the sector's middle half▲ 17.1%€541,159above the sector's middle half▲ 30.1%€459,132above the sector's middle half▼ 15.2%€519,552above the sector's middle half▲ 13.2%€612,759above the sector's middle half▲ 17.9%
Total assets€426,746within the sector's middle half▲ 7.5%€567,282within the sector's middle half▲ 32.9%€536,467within the sector's middle half▼ 5.4%€588,911within the sector's middle half▲ 9.8%€629,243above the sector's middle half▲ 6.8%
Debt€10,676▼ 74.3%€26,123▲ 145%€77,335▲ 196%€69,359▼ 10.3%€16,483▼ 76.2%
Working capital€314,262above the sector's middle half▲ 35.9%€454,053above the sector's middle half▲ 44.5%€398,723above the sector's middle half▼ 12.2%€451,330above the sector's middle half▲ 13.2%€555,679above the sector's middle half▲ 23.1%
Solvency97.5%above the sector's middle half▲ 8.0pp95.4%above the sector's middle half▼ 2.1pp85.6%above the sector's middle half▼ 9.8pp88.2%above the sector's middle half▲ 2.6pp97.4%above the sector's middle half▲ 9.2pp
Current ratio30.44above the sector's middle half▲ 23.8718.38above the sector's middle half▼ 12.056.16within the sector's middle half▼ 12.237.51above the sector's middle half▲ 1.3534.71above the sector's middle half▲ 27.20
Return on assets (ROA)14.2%within the sector's middle half▲ 18.9pp22.1%within the sector's middle half▲ 7.8pp21.7%within the sector's middle half▼ 0.3pp10.3%within the sector's middle half▼ 11.5pp14.8%within the sector's middle half▲ 4.6pp
Staff (FTE)11=1.1▲ 10.0%1.3▲ 18.2%
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 15% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €629,243
Fixed assets
€57,080 ▼ 16.3%
Current assets
€572,163 ▲ 9.9%
Equity and liabilities €629,243
Equity
€612,759 ▲ 17.9%
Debt
€16,483 ▼ 76.2%
Debt's share of the balance-sheet total falls from 11.8% to 2.6%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€118,956▲
2024 · €104,579
Cash flow
€107,197▲
2024 · €73,647
Debt to equity
0.03▼
2024 · 0.13
ROE
15.2%▲
2024 · 11.6%
Interest coverage
203.05▲
2024 · 79.64
Debt ≤ 1 year
€16,483▼
2024 · €69,359
Income taxes
€46,309▲
2024 · €29,892
Staff costs
€17,462▼
2024 · €20,266
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 31,349 companies that looked in July 2024 the way this one looks now, 0.4% went bankrupt within 24 months and 93% are still going.
- Micro
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.4%
went bankrupt
5.9%
stopped otherwise
93%
still going
A further 0.2% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 31,349 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | €6,000 | €1,058 | - | - |
| Remuneration, social security and pensions62 | €14,826 | €17,288 | €18,474 | €20,266 | €17,462 | ▼ 13.8% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €24,556 | €19,867 | €8,009 | €13,227 | €13,990 | ▲ 5.8% |
| Other operating charges640/8 | €4,772 | €4,589 | €4,053 | €4,395 | €853 | ▼ 80.6% |
| Non-recurring operating charges66A | - | €112 | - | - | - | - |
| Gross operating margin9900 | €124,484 | €223,414 | €201,812 | €129,240 | €137,271 | ▲ 6.2% |
| Operating profit (loss)9901 | €80,330 | €181,557 | €171,276 | €91,352 | €104,965 | ▲ 14.9% |
| Financial income75/76B | €3,552 | €4,119 | €27 | €274 | €36,009 | ▲ 13,050% |
| Recurring financial income75 | €3,552 | €4,119 | €27 | €274 | €35,729 | ▲ 12,948% |
| Non-recurring financial income76B | - | - | - | - | €280 | - |
| Financial charges65/66B | €826 | €623 | €360 | €1,313 | €1,458 | ▲ 11.1% |
| Recurring financial charges65 | €826 | €623 | €360 | €1,313 | €586 | ▼ 55.4% |
| Non-recurring financial charges66B | - | - | - | - | €872 | - |
| Profit (loss) for the period before taxes9903 | €83,056 | €185,053 | €170,943 | €90,312 | €139,516 | ▲ 54.5% |
| Income taxes67/77 | €22,401 | €59,964 | €54,408 | €29,892 | €46,309 | ▲ 54.9% |
| Profit (loss) for the period9904 | €60,656 | €125,089 | €116,535 | €60,420 | €93,207 | ▲ 54.3% |
| Profit (loss) for the period to be appropriated9905 | €60,656 | €125,089 | €116,535 | €60,420 | €93,207 | ▲ 54.3% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €426,746 | €567,282 | €536,467 | €588,911 | €629,243 | ▲ 6.8% |
| Fixed assets21/28 | €101,808 | €87,106 | €60,409 | €68,222 | €57,080 | ▼ 16.3% |
| Tangible fixed assets22/27 | €101,808 | €87,106 | €60,409 | €68,222 | €57,080 | ▼ 16.3% |
| Land and buildings22 | €86,613 | €69,629 | €17,611 | €23,449 | €14,043 | ▼ 40.1% |
| Plant, machinery and equipment23 | - | €3,955 | €2,846 | €3,173 | €4,838 | ▲ 52.5% |
| Furniture and vehicles24 | €15,196 | €13,522 | €39,952 | €41,600 | €38,198 | ▼ 8.2% |
| Current assets29/58 | €324,938 | €480,176 | €476,058 | €520,690 | €572,163 | ▲ 9.9% |
| Amounts receivable after more than one year29 | €128,020 | €175,020 | €273,666 | €349,839 | - | - |
| Trade receivables290 | €128,020 | €175,020 | €273,666 | €349,839 | - | - |
| Amounts receivable within one year40/41 | €6,369 | - | €84,704 | €17,477 | €384,589 | ▲ 2,101% |
| Trade receivables40 | €3,770 | - | €11,977 | €5,294 | €245 | ▼ 95.4% |
| Other amounts receivable41 | €2,599 | - | €72,726 | €12,183 | €384,344 | ▲ 3,055% |
| Current investments50/53 | - | - | - | €84,878 | €86,628 | ▲ 2.1% |
| Cash at bank and in hand54/58 | €119,616 | €221,765 | €112,384 | €63,481 | €88,273 | ▲ 39.1% |
| Deferred charges and accrued income490/1 | €70,933 | €83,391 | €5,304 | €5,014 | €12,673 | ▲ 153% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €426,746 | €567,282 | €536,467 | €588,911 | €629,243 | ▲ 6.8% |
| Equity10/15 | €416,070 | €541,159 | €459,132 | €519,552 | €612,759 | ▲ 17.9% |
| Contributions10/11 | €64,050 | €64,050 | €64,050 | €64,050 | €64,050 | = |
| Reserves13 | €352,019 | €477,109 | €395,082 | €455,502 | €548,709 | ▲ 20.5% |
| Non-distributable reserves130/1 | €6,405 | €6,405 | - | - | - | - |
| Reserves not available under the articles1311 | €6,405 | €6,405 | - | - | - | - |
| Distributable reserves133 | €345,614 | €470,704 | €395,082 | €455,502 | €548,709 | ▲ 20.5% |
| Amounts payable17/49 | €10,676 | €26,123 | €77,335 | €69,359 | €16,483 | ▼ 76.2% |
| Amounts payable within one year42/48 | €10,676 | €26,123 | €77,335 | €69,359 | €16,483 | ▼ 76.2% |
| Trade debts44 | €7,754 | €11,730 | €6,280 | €6,285 | €7,432 | ▲ 18.2% |
| Suppliers440/4 | €7,754 | €11,730 | €6,280 | €6,285 | €7,432 | ▲ 18.2% |
| Taxes, remuneration and social security45 | €2,922 | €7,208 | €24,225 | €16,245 | €6,051 | ▼ 62.8% |
| Taxes450/3 | €939 | €4,964 | €21,670 | €14,400 | €6,051 | ▼ 58.0% |
| Remuneration and social security454/9 | €1,983 | €2,245 | €2,555 | €1,845 | - | - |
| Other amounts payable47/48 | - | €7,184 | €46,829 | €46,829 | €3,000 | ▼ 93.6% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €60,656 | €125,089 | €116,535 | €60,420 | €93,207 | ▲ 54.3% |
| + Depreciation and write-downs630 | €24,556 | €19,867 | €8,009 | €13,227 | €13,990 | ▲ 5.8% |
| Operating cash flow (approximation) | €85,211 | €144,956 | €124,544 | €73,647 | €107,197 | ▲ 45.6% |
| Investment in fixed assets (approximation) | - | -€5,164 | €18,688 | -€21,040 | -€2,848 | ▲ 86.5% |
| Change in cash | - | €102,149 | -€109,381 | -€48,903 | €24,792 | ▲ 151% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
20-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 20 days late
2025
31-12
Financial
Liquidity times 5current ratio 34.71
Current ratio from 7.51 to 34.71; short-term debt falls from €69,359 to €16,483.
22-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Equity above €500,000Eq €519,552 ▲13.2%
4 profitable years in a row build equity to €519,552.
14-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
22-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 22 days late
2022
31-12
Financial
Highest result since 2018net €125,089 ▲106%
Operating result €181,557, net result €125,089, both a record.
31-12
Financial
Equity above €500,000Eq €541,159 ▲30.1%
2 profitable years in a row build equity to €541,159.
16-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Back to profitnet €60,656
Net result €60,656 after one loss-making year.
31-12
Financial
Liquidity times 5current ratio 30.44
Current ratio from 6.56 to 30.44; short-term debt falls from €41,580 to €10,676.
29-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Show earlier events
2020
31-12
Financial
Weakest financial yearnet -€18,501
Net result drops to -€18,501, the lowest in the series; recovery starts the following year.
28-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 28 days late
2019
19-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
10-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 10 days late
2017
30-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 30 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Hasselt · 1 establishment unit since 1998
Ground area
2,918 m²
Building footprint
328 m²
Volume, LiDAR
1,366 m³
Parcel 71328D0439/00N002, Flanders · tallest building 8.7 m, ±1 floor. Linked by address, not a title deed.
3
companies at this address
See who is registered here
1 establishment unit
Singelbeekstraat 157, 3500 Hasselt
since 19982.228.859.367
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71328D0439/00N002 | Flanders | 2,918 m² | 1 · 328 m² | 8.7 m · 1 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr.Kerssebeeck-Dr.Berends
BE 0898.434.784
Hasselt · Eq €612,780
VAN BELLE CARDIOLOGIE
BE 0848.439.402
Hasselt · Eq €612,669
DOKTER KALAYCI Kazim
BE 0598.984.601
Aartselaar · Eq €612,872
DOKTER ERWIN SCHROYENS
BE 0476.755.988
Mechelen · Eq €612,575
DR. MARC DETOLLENAERE
BE 0472.021.794
Koksijde · Eq €612,994
Of 16,629 companies in sector 86220 we hold annual accounts for 7,986. 6,277 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded12-11-1998
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
Contact
E-mail
drtcox@gmail.comHasselt
Phone
011.22.16.18Hasselt
E-invoicing
Reachable via Peppol
Peppol ID
0208:0464574768
Also
9925:BE0464574768
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.